On October 22nd, according to BusinessWire, Applied DNA Sciences (NASDAQ: BNBX), a listed biotechnology company in the United States, announced the successful completion of the previously announced Private Equity (PIPE) financing, with a total fundraising amount of about 27 million US dollars. In the future, it may receive up to 31 million dollars through warrants call-over.
The company officially launched its revenue-focused digital asset treasury strategy. The financing proceeds included $15.30 million in cash and stablecoins, as well as OBNB trust units worth $11.71 million. The company received a total of 435,638 trust units, representing underlying ownership of 10,647 BNB tokens. In addition, Applied DNA Sciences purchased an additional 4,908 BNB tokens.
Chief Investment Officer Patrick Horsman said the company sees BNB as the next institutional blockchain. The company plans to use the net proceeds to continue implementing the BNB treasury strategy, support Working Funds requirements, and cover transaction-related expenses.
Applied DNA Sciences announced that it holds more than $17 million worth of BNB.
2025-10-22 12:31:58
Disclaimer:
1. The information provided does not constitute investment advice. Investors should make independent decisions and bear all risks themselves.
2. The copyright of this content belongs to the original author. The views expressed herein are solely those of the author and do not represent the stance or position of this website.
Previous article：
美股上市公司 Applied DNA Sciences 宣布持有价值超 1700 万美元的 BNBNext article：
Forward Industries 组建 25 人加密货币顾问委员会，以推进 SOL 财库战略
